A Life In Genes: Scrip Award Winner Sir Gregory Winter's Speech
This article was originally published in Scrip
Executive Summary
The 2015 Scrip Lifetime Achievement Award was given to Sir Gregory Winter, Master of Trinity College, Cambridge (UK). Founder of Cambridge Antibody Technology (acquired by AstraZeneca), Domantis (acquired by GlaxoSmithKline) and Bicycle Therapeutics, he is best known for his pioneering research into humanizing antibodies. His findings led to the development of the first human antibody, Humira (adalimumab), until very recently the world's top-selling drug.
You may also be interested in...
Father of Humira, Greg Winter, Wins 2018 Nobel Prize For Chemistry
The man behind Humira, Sir Greg Winter, has been jointly awarded the 2018 Nobel Prize for Chemistry for his pioneering work on antibodies which led to the development of the world’s most successful drug.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.